NCT01831505 2017-02-27
Feasibility of Assessing Lymphoma Response to Precise Local Injection of Candidate Chemotherapy Agents
Presage Biosciences
Phase 1 Completed
Presage Biosciences
Istituto Clinico Humanitas
National Cancer Institute (NCI)
National Cancer Institute (NCI)